Simon Barry J., a director at ImmunityBio, Inc. ($IBRX), sold about $3.8 million in company shares through five open market transactions over the past year. His most recent sale occurred on February 24, 2026. These sales rank him 2,329th among 11,678 individual insiders by total value sold, below the average of $8.6 million across about 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 24, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | S | Common Stock | 75000 | $12.01 | 2,850,821.0000 | 984,965,179 | 2.56% | 0.01% |
| Feb. 20, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | S | Common Stock | 10000 | $9.25 | 3,081,604.0000 | 984,965,179 | 0.32% | 0.00% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Common Stock | 15243 | $0.00 | 3,096,847.0000 | 984,965,179 | 0.49% | 0.00% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | F | Common Stock | 6026 | $8.70 | 3,090,821.0000 | 984,965,179 | 0.19% | 0.00% |
| Feb. 23, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | S | Common Stock | 165000 | $10.25 | 2,925,821.0000 | 984,965,179 | 5.34% | 0.02% |
| Feb. 22, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Restricted Stock Units | 15243 | $0.00 | 15,245.0000 | 984,965,179 | 50.00% | 0.00% |
| Jan. 20, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | S | Common Stock | 75000 | $7.88 | 3,091,604.0000 | 984,965,179 | 2.37% | 0.01% |
| Jan. 20, 2026 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | S | Common Stock | 76967 | $6.54 | 3,166,604.0000 | 984,965,179 | 2.37% | 0.01% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Restricted Stock Units | 15243 | $0.00 | 30,488.0000 | 852,904,340 | 33.33% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | F | Common Stock | 5453 | $3.42 | 3,243,571.0000 | 852,904,340 | 0.17% | 0.00% |
| Feb. 22, 2025 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Common Stock | 15243 | $0.00 | 3,249,024.0000 | 852,904,340 | 0.47% | 0.00% |
| Jan. 22, 2025 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Common Stock | 110020 | $2.00 | 3,233,781.0000 | 852,904,340 | 3.52% | 0.01% |
| Jan. 22, 2025 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Stock Option (right to buy) | 110020 | $0.00 | 0.0000 | 852,904,340 | 100.00% | 0.01% |
| June 20, 2024 | Viracta Therapeutics, Inc. | $VIRX | Simon Barry J. | Not found | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 39,272,434 | 9999.99% | 0.13% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | A | Stock Option (right to buy) | 159146 | $0.00 | 159,146.0000 | 670,867,344 | 9999.99% | 0.02% |
| Feb. 22, 2024 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | A | Restricted Stock Units | 45731 | $0.00 | 45,731.0000 | 670,867,344 | 9999.99% | 0.01% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | F | Common Stock | 22094 | $3.36 | 3,123,761.0000 | 670,867,344 | 0.70% | 0.00% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Restricted Stock Units | 57200 | $0.00 | 0.0000 | 670,867,344 | 100.00% | 0.01% |
| Jan. 31, 2024 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Common Stock | 57200 | $0.00 | 3,145,855.0000 | 670,867,344 | 1.85% | 0.01% |
| Sept. 1, 2023 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Restricted Stock Units | 57199 | $0.00 | 57,200.0000 | 421,569,115 | 50.00% | 0.01% |
| Sept. 1, 2023 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | M | Common Stock | 57199 | $0.00 | 3,088,655.0000 | 421,569,115 | 1.89% | 0.01% |
| Aug. 25, 2023 | ImmunityBio, Inc. | $IBRX | Simon Barry J. | Director | A | Restricted Stock Units | 114399 | $0.00 | 114,399.0000 | 421,569,115 | 9999.99% | 0.03% |